NCT03419910View on ClinicalTrials.gov

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

May 4, 2018

Study Completion Date

May 4, 2018

Conditions
Psoriasis
Interventions
DRUG

BMS-986165

Specified dose on specified days

DRUG

Cyclosporine

Specified dose on specified days

Trial Locations (1)

84124

PRA Health Sciences, Salt Lake City

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY